Brief: Sangamo Therapeutics Reports On Topline Results From Phase 3 Trial Of Hemophilia A Gene Therapy Candidate
24/07/2024 13:03
July 24 (Reuters) - Sangamo Therapeutics Inc SGMO.O :
* SANGAMO THERAPEUTICS REPORTS ON PFIZER’S ANNOUNCEMENT OF
POSITIVE TOPLINE RESULTS FROM PHASE 3 TRIAL OF HEMOPHILIA A GENE
THERAPY CANDIDATE
Source text for Eikon: ID:nBw8pwQmBa
Further company coverage: SGMO.O
((Reuters.Briefs@thomsonreuters.com;))